Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
3/1/2021
Junshi Bio and AstraZeneca Announce Strategic Collaboration to Commerc...
3/1/2021
NMPA Solicits Comments on the Draft Measures for Control of Vaccine Pr...
3/1/2021
Bayer Signs Strategic Alliance MOU with China Alliance for Rare Diseas...
3/1/2021
Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie
3/1/2021
Eisai Secures Anti-Insomnia Drug Dayvigo in Hong Kong
3/1/2021
FiercePharma: AZ Licenses Junshi's PD-1 in China in a Bizarre Commerci...
2/27/2021
MNC China Business Slows by VBP, Which May Be Expanding to Biologics S...
2/26/2021
241 A Share-Listed Chinese MedPharm Cos Release 2020 Performance Guida...
2/26/2021
Financial-related Company News in Brief
2/26/2021
Recent Executive Moves
2/26/2021
NMPA Announces Package Insert Revision of Misoprostol Tablets
2/26/2021
CANbridge Pharma and Puma Biotech Agree to Terminate NERLYNX License...
2/25/2021
CDE Issues the Technical Guidelines for Non-clinical Studies of Radioa...
2/25/2021
CDE Seeks Comments on Implementation Advice on ICH Guidelines Q5D, M9 ...
2/25/2021
AstraZeneca Gains Default Chinese IND Approval for Its Class 1 New Bio...
2/25/2021
Snapshot of BMI System Financial Performance in 2020
2/25/2021
China Approves Two More Domestic COVID-19 Vaccines
2/25/2021
Puma Biotech and Pierre Fabre Amend NERLYNX License Deal to Include G...
2/25/2021
Harbour BioMed Announces Chinese IND Approval of for Combo Therapy of ...
2/25/2021
PharmaNJ's China NMPA Approved Tracker: Jan 2021
2/25/2021
Biosecurity Law of the P.R.C. - Full Text Unofficial Translation
2/24/2021
Review of Chinese Import Chemical Drug IND Applications in 2020
2/24/2021
Snapshot of MNC Products in the 2020 NRDL
2/24/2021
Kuehne+Nagel Forms Strategic Partnership with Chinese Pharma Specialis...
2/24/2021
Gannex Receives U.S. IND Approval for THR-β Agonist ASC41 for NASH
2/23/2021
NMPA Issues the List of Reference Formulations for GQCE Studies (38th ...
2/23/2021
CDE Issues New Guideline Document for Publication of Technical Evaluat...
2/23/2021
NMPA Solicits Comments on the Draft Technical Guidelines for Non-clini...
2/23/2021
Indian Pharma Firms Go Local Seeking to End Reliance on China
2/23/2021
Solentim Expands Gglobal Rreach, Opening New Operation in China
Page:
142
/
719
Total number of articles:
21555
:
[First]
[<<]
[140]
[141]
[142]
[143]
[144]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit